These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2985774)

  • 1. Disposition and bioavailability of various formulations of tetrahydrocannabinol in the rhesus monkey.
    Perlin E; Smith CG; Nichols AI; Almirez R; Flora KP; Cradock JC; Peck CC
    J Pharm Sci; 1985 Feb; 74(2):171-4. PubMed ID: 2985774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rectal bioavailability of delta-9-tetrahydrocannabinol from the hemisuccinate ester in monkeys.
    ElSohly MA; Stanford DF; Harland EC; Hikal AH; Walker LA; Little TL; Rider JN; Jones AB
    J Pharm Sci; 1991 Oct; 80(10):942-5. PubMed ID: 1664466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating concentrations of the antiprogestins CDB-2914 and mifepristone in the female rhesus monkey following various routes of administration.
    Larner JM; Reel JR; Blye RP
    Hum Reprod; 2000 May; 15(5):1100-6. PubMed ID: 10783360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rectal bioavailability of delta-9-tetrahydrocannabinol from various esters.
    Elsohly MA; Little TL; Hikal A; Harland E; Stanford DF; Walker L
    Pharmacol Biochem Behav; 1991 Nov; 40(3):497-502. PubMed ID: 1666913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women.
    Wall ME; Sadler BM; Brine D; Taylor H; Perez-Reyes M
    Clin Pharmacol Ther; 1983 Sep; 34(3):352-63. PubMed ID: 6309462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTL401, a New Formulation Based on Pro-Nano Dispersion Technology, Improves Oral Cannabinoids Bioavailability in Healthy Volunteers.
    Atsmon J; Cherniakov I; Izgelov D; Hoffman A; Domb AJ; Deutsch L; Deutsch F; Heffetz D; Sacks H
    J Pharm Sci; 2018 May; 107(5):1423-1429. PubMed ID: 29287930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolism of delta 9-tetrahydrocannabinol and related cannabinoids in man.
    Wall ME; Perez-Reyes M
    J Clin Pharmacol; 1981; 21(S1):178S-189S. PubMed ID: 6271823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of delta 9-tetrahydrocannabinol during the follicular phase of the rhesus monkey (Macaca mulatta).
    Asch RH; Smith CG; Siler-Khodr TM; Pauerstein CJ
    J Clin Endocrinol Metab; 1981 Jan; 52(1):50-5. PubMed ID: 6256405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and Tolerability of Δ9-THC-Hemisuccinate in a Suppository Formulation as an Alternative to Capsules for the Systemic Delivery of Δ9-THC.
    ElSohly MA; Gul W; Walker LA
    Med Cannabis Cannabinoids; 2018 Jun; 1(1):44-53. PubMed ID: 34676321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sublingual administration of Delta9-tetrahydrocannabinol/beta-cyclodextrin complex increases the bioavailability of Delta9-tetrahydrocannabinol in rabbits.
    Mannila J; Järvinen T; Järvinen K; Tervonen J; Jarho P
    Life Sci; 2006 Mar; 78(17):1911-4. PubMed ID: 16266727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking.
    Ohlsson A; Lindgren JE; Wahlen A; Agurell S; Hollister LE; Gillespie HK
    Clin Pharmacol Ther; 1980 Sep; 28(3):409-16. PubMed ID: 6250760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of isoxicam following intravenous, intramuscular, oral and rectal administration in healthy volunteers.
    Kölle EU; Vollmer KO
    Br J Clin Pharmacol; 1986; 22 Suppl 2(Suppl 2):135S-141S. PubMed ID: 3620273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal absorption of Delta(9)-tetrahydrocannabinol and WIN55,212-2 mesylate in rats.
    Valiveti S; Agu RU; Hammell DC; Paudel KS; Earles DC; Wermeling DP; Stinchcomb AL
    Eur J Pharm Biopharm; 2007 Feb; 65(2):247-52. PubMed ID: 17014999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal disposition of delta 9-tetrahydrocannabinol (THC) during late pregnancy in the rhesus monkey.
    Bailey JR; Cunny HC; Paule MG; Slikker W
    Toxicol Appl Pharmacol; 1987 Sep; 90(2):315-21. PubMed ID: 2820086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of orally and rectally administered delta 9-tetrahydrocannabinol on spasticity: a pilot study with 2 patients.
    Brenneisen R; Egli A; Elsohly MA; Henn V; Spiess Y
    Int J Clin Pharmacol Ther; 1996 Oct; 34(10):446-52. PubMed ID: 8897084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and pharmacokinetic characterization of pulmonal and intravenous delta-9-tetrahydrocannabinol (THC) in humans.
    Naef M; Russmann S; Petersen-Felix S; Brenneisen R
    J Pharm Sci; 2004 May; 93(5):1176-84. PubMed ID: 15067694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental study of an ampicillin suppository (KS-R1) in adults and children].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Kuda N; Ishimoto K
    Jpn J Antibiot; 1983 Jul; 36(7):1713-68. PubMed ID: 6655809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of benzquinamide in man.
    Hobbs DC; Connolly AG
    J Pharmacokinet Biopharm; 1978 Dec; 6(6):477-85. PubMed ID: 581593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentobarbital absorption from capsules and suppositories in humans.
    Doluisio JT; Smith RB; Chun AH; Dittert LW
    J Pharm Sci; 1978 Nov; 67(11):1586-8. PubMed ID: 712597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.